A new Malaria Vaccine developed by Oxford University, called R21, has been recommended by the World Health Organization (WHO) for the prevention of malaria in children. The vaccine is not only effective but also easier to make and more affordable, making it accessible to a greater number of African countries. The R21 vaccine, along with the previously recommended RTS,S vaccine, is expected to have a major public health impact in the African region. Demand for malaria vaccines is high, and the addition of R21 will help boost the limited supply of RTS,S and protect more children from the deadly disease.

The post New Oxford Malaria Vaccine is ‘Huge Advance’ to Protect Children From Deadly Killer appeared first on Balanced News Summary.